Download PDF
Thromb Haemost 1995; 74(05): 1323-1328
DOI: 10.1055/s-0038-1649934
Original Article
Platelets
Schattauer GmbH Stuttgart

Different Abilities of Thrombin Receptor Activating Peptide and Thrombin to Induce Platelet Calcium Rise and Full Release Reaction

Dominique Lasne
1   Inserm U 428, Faculté de Pharmacle, Paris, France
2   Laboratolre d’Hémostase, Hopital Broussals, Paris, France
,
José Donato
1   Inserm U 428, Faculté de Pharmacle, Paris, France
3   Department of Pharmacology, Faculty of Medical Sciences of States, University of Campinas, Campinas, SP, Brazil
,
Hervé Falet
1   Inserm U 428, Faculté de Pharmacle, Paris, France
,
Francine Rendu
1   Inserm U 428, Faculté de Pharmacle, Paris, France
› Author Affiliations
Further Information

Publication History

Received 14 April 1995

Accepted after resubmission 04 August 1995

Publication Date:
10 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Synthetic peptides (TRAP or Thrombin Receptor Activating Peptide) corresponding to at least the first five aminoacids of the new N-terminal tail generated after thrombin proteolysis of its receptor are effective to mimic thrombin. We have studied two different TRAPs (SFLLR, and SFLLRN) in their effectiveness to induce the different platelet responses in comparison with thrombin. Using Indo-1/AM- labelled platelets, the maximum rise in cytoplasmic ionized calcium was lower with TRAPs than with thrombin. At threshold concentrations allowing maximal aggregation (50 μM SFLLR, 5 μM SFLLRN and 1 nM thrombin) the TRAPs-induced release reaction was about the same level as with thrombin, except when external calcium was removed by addition of 1 mM EDTA. In these conditions, the dense granule release induced by TRAPs was reduced by over 60%, that of lysosome release by 75%, compared to only 15% of reduction in the presence of thrombin. Thus calcium influx was more important for TRAPs-induced release than for thrombin-induced release. At strong concentrations giving maximal aggregation and release in the absence of secondary mediators (by pretreatment with ADP scavengers plus aspirin), SFLLRN mobilized less calcium, with a fast return towards the basal level and induced smaller lysosome release than did thrombin. The results further demonstrate the essential role of external calcium in triggering sustained and full platelet responses, and emphasize the major difference between TRAP and thrombin in mobilizing [Ca2+]j. Thus, apart from the proteolysis of the seven transmembrane receptor, another thrombin binding site or thrombin receptor interaction is required to obtain full and complete responses.

 

  • References

  • 1 Vu T-KH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-1068
    CrossrefPubMedSearch in Google Scholar
  • 2 Rasmussen UB, Vouret-Craviari V, Jallal S, Schlcsinger Y, Pagès G, Pavirani A, Lecocq JP, Pouysségur J, Van Ohherghen-Schilling E. cDNA cloning anti expression of a hamster α-thrombin receptor coupled to Ca2+mobili/ation. FEBS Lett 1991; 288: 123-128
    CrossrefPubMedSearch in Google Scholar
  • 3 Vu T-KH, Wheaton VI, Hung DT, Charo I, Coughlin SR. Domains specifying thrombin-receptor interaction. Nature 1991; 353: 674-677
    CrossrefPubMedSearch in Google Scholar
  • 4 Gersztcn RE, Chen JI, Ishii M, Ishii K, Wang L, Naneviez T, Turek CW, Vu T-KH, Coughlin SR. Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface. Nature 1994; 368: 648-651
    CrossrefPubMedSearch in Google Scholar
  • 5 Chen J, Ishii M, Wang L, Ishii K, Coughlin SR. Thrombin receptor activation. J Biol Chem 1994; 269: 16041-16045
    PubMedSearch in Google Scholar
  • 6 Chao BH, Kalkunte S, Maraganore JM, Stone SR. Essential groups in synthetic agonist peptides for activation of platelet thrombin receptor. Biochemistry 1992; 31: 6175-6178
    CrossrefPubMedSearch in Google Scholar
  • 7 Sabo T, Gurwitz D, Motola L, Brodt P, Barak R, Elhanaty E. Structure-activity studies of the thrombin receptor activating peptide. Biochem Biophys Res Commun 1992; 188: 604-610
    CrossrefPubMedSearch in Google Scholar
  • 8 Vassallo RR, Kieher-Emmons T, Cichowski K, Brass LF. Structure-function relationships in the activation of platelet thrombin receptors by recep- tor-derivated peptides. J Biol Chem 1992; 267: 6081-6085
    PubMedSearch in Google Scholar
  • 9 Vouret-Craviari V, Van Obberghen-Schilling E, Scimeca JC, Van Obber-ghen E, Pouysségur J. Differential activation of p44 ntpapk”i,k(ERK1) by α-thrombin-receptor peptide agonist. Biochem J 1993; 289: 209-214
    CrossrefPubMedSearch in Google Scholar
  • 10 Howells GL, Macey M, Curtis MA, Stone SR. Peripheral blood lymphocytes express the platelet-type thrombin receptor. Brit J Haematol 1993; 84: 156-160
    CrossrefPubMedSearch in Google Scholar
  • 11 Huang RS, Sorisky A, Church WR, Simons ER, Rittenhouse SE. ”Thrombin” receptor-directed ligand accounts for activation by thrombin of platelet phospholipase C and accumulation of 3-phosphorylated phosphoinositides. J Biol Chem 1991; 266: 18435-18443
    PubMedSearch in Google Scholar
  • 12 Seiler SM, Michel IM, Fenton II J W. Involvement of the ”tethered-ligand” receptor in thrombin inhibition of platelet adenylate cyclase. Biochem Biophys Res Commun 1992; 182: 1296-1302
    CrossrefPubMedSearch in Google Scholar
  • 13 Lau LF, Pumiglia K, Côté YP, Feinstein MB. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activationand signal transduction in human platelets in the absence of platelet-derived secondary mediators. Biochem J 1994; 303: 391-400
    CrossrefPubMedSearch in Google Scholar
  • 14 Kinlough-Rathbone RL, Perry DW, Guccione MA, Rand ML, Packham MA. Degranulation of human platelets by the thrombin receptor peptide SFLLRN: comparison with degranulation by thrombin. Thromb Haemost 1993; 70: 1019-1023
    Thieme ConnectPubMedSearch in Google Scholar
  • 15 Goodwin CA, Wheeler-Jones CP D, Kakkar VV, Deadman JJ, Authi KS, Scully MF. Thrombin receptor activating peptide does not stimulate platelet procoagulant activity. Biochem Biophys Res Commun 1994; 202: 321-327
    CrossrefPubMedSearch in Google Scholar
  • 16 Davies TA, Drotts DL, Weil GJ, Simons ER. Cytoplasmic Ca2+ is necessary for thrombin-induced platelet activation. J Biol Chem 1989; 264: 19600-19606
    PubMedSearch in Google Scholar
  • 17 Walker TR, Watson SP. Synergy between Ca2+ and protein kinase C is the major factor in determining the level of secretion from human platelets. Biochem J 1993; 289: 277-282
    CrossrefPubMedSearch in Google Scholar
  • 18 Rendu F, Marche P, Maclouf J, Girard A, Levy-Toledano S. Triphospho- inositides breakdown and dense body release as the earliest events in thrombin-induced activation of human platelets. Biochem Biophys Res Commun 1983; 116: 513-519
    CrossrefPubMedSearch in Google Scholar
  • 19 Coller BS, Ward P, Ceruso M, Scudder LE, Springer K, Kutok J, Prestwich GD. Thrombin receptor activating peptides: importance of the N-terminal serine and its ionization state as judged by PH dependence, nuclear magnetic resonance spectroscopy, and cleavage by aminopeptidease M. Biochemistry 1992; 31: 11713-11720
    CrossrefPubMedSearch in Google Scholar
  • 20 Holmsen H, Day HJ, Storm E. Adenine nucleotide metabolism of blood platelets VI. Subcellular localization of nucleotide pools with different functions in the platelet release reaction Biochim Biophys Acta 1969; 186: 254-266
    CrossrefPubMedSearch in Google Scholar
  • 21 Rendu F, Maclouf J, Launay JM, Boinot C, Levy-Toledano S, Tanzer J, Caen J. Hermansky-Pudlak platelets: further studies on release reaction and protein phosphorylations. Am J Hematol 1987; 25: 165-174
    CrossrefPubMedSearch in Google Scholar
  • 22 Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-3450
    PubMedSearch in Google Scholar
  • 23 Lages B, Dangelmaler CA, Holmsen H, Weiss JH. Specific correction of impaired acid hydrolase secretion in storage pool-deficient platelets by adenosine diphosphate. J Clin Invest 1988; 81: 1865-1872
    CrossrefPubMedSearch in Google Scholar
  • 24 Holmsen H, Dangelmaier CA, Holmsen HK. Thrombin-induced platelet responses differ in requirement for receptor occupancy. J Biol Chem 1981; 256: 9393-9396
    PubMedSearch in Google Scholar
  • 25 Nieuwland A, Van Willigen G, Akkerman NJ W. Different pathways for control of Na+/H+ exchange via activation of the thrombin receptor. Bio-chem J 1994; 297: 47-52
    CrossrefPubMedSearch in Google Scholar
  • 26 Greco N, Jamieson GA. High and moderate affinity pathways for a-throm- bin-induced platelet activation. Proc Soc Exp Biol Med 1991; 198: 792-799
    CrossrefPubMedSearch in Google Scholar
  • 27 Jandrot-Perrus M, Rendu F, Caen JP, Levy-Toledano S, Guillin MC. The common pathway for alpha- and gamma-thrombin-induced platelet activation is independent of GPIb: a study of Bernard-Soulier platelets. Brit J Haematol 1990; 75: 385-392
    CrossrefPubMedSearch in Google Scholar
  • 28 De Marco L, Mazzucato M, Masotti A, Fenton II J W, Ruggeri ZM. Function of glycoprotein Iba in platelet activation induced by α-thrombin. J Biol Chem 1991; 266: 23776-23783
    PubMedSearch in Google Scholar
  • 29 Jandrot-Perrus M, Clemetson KJ, Huisse MG, Guillin MC. Thrombin interaction with platelet glycoprotein lb: effect of glycocalicin on thrombin specificity. Blood 1992; 80: 2781-2786
    PubMedSearch in Google Scholar
  • 30 Kinlough-Rathbone RL, Perry DW, Packham MA. Contrasting effects of thrombin and the thrombin receptor peptide, SFLLRN, on aggregation and release of14C-serotonin by human platelets pretreated with chymotrypsin or serratia marcescens protease. Thromb Haemost 1995; 73: 122-125
    Thieme ConnectPubMedSearch in Google Scholar
  • 31 Connoly TM, Condra C, Feng DM, Cook JJ, Stranieri MT, Reilly CF, Nutt RF, Gould RJ. Species variability in platelet and other cellular responsiveness to thrombin receptor-derivated peptides. Thromb Haemost 1994; 72: 627-633
    Thieme ConnectPubMedSearch in Google Scholar
  • 32 Jenkins AL, Bootman MD, Berridge MJ, Stone SR. Differences in intracellular calcium signaling after activation of the thrombin receptor by thrombin and agonist peptide in osteoblast-like cells. J Biol Chem 1994; 269: 17104-17110
    PubMedSearch in Google Scholar
  • 33 Jakubowski JA, Maraganore JM. Inhibition of coagulation and thrombin- induced platelet activities by a synthetic dodecapeptide modeled on the car- boxy-terminus of hirudin. Blood 1990; 75: 399-406
    PubMedSearch in Google Scholar
  • 34 Liu LW, Vu T-KH, Esmon CT, Coughlin SR. The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity. J Biol Chem 1991; 266: 16977-16980
    PubMedSearch in Google Scholar
  • 35 Leong L, Henriksen RA, Kermode JC, Rittenhouse SE, Tracy PB. The thrombin high-affinity binding site on platelets is a negative regulator of thrombin-induced platelet activation. Structure-function studies using two mutant thrombins, Quick I and Quick II Biochemistry 1992; 31: 2567-2576
    CrossrefPubMedSearch in Google Scholar
  • 36 Wu Q, Picard V, Aiach M, Sadler JE. Activation induced exposure of the thrombin anion-binding exosite: studies with recombinant mutant prothrombins and an antithrombin antibody. J Biol Chem 1994; 269: 3725-3730
    PubMedSearch in Google Scholar
  • 37 Arnaud E, Lafay M, Gaussem P, Picard V, Jandrot-Perrus M, Aiach M, Rendu F. An autoantibody directed against human thrombin anion-binding exosite in a patient with arterial thrombosis: effects on platelets, endothelial cells, and protein C activation. Blood 1994; 84: 1843-1850
    PubMedSearch in Google Scholar